RxAnte,Monarch Medical Technologies,LunaJoy
Komodo Health banks $200M equity infusion to fuel growth as it restructures, cuts head count by 9%
Health data startup Komodo Health secured a structured equity infusion of $200 million in early November as it looks to continue scaling its data-driven "healthcare map" and analytics tools.
Coatue Management led the new investment with Dragoneer Investment Group contributing.
Komodo Health continues to experience strong growth despite volatile market headwinds, Web Sun, company president and co-founder, told Fierce Healthcare in an exclusive interview. The company has raised $514 million to date with $314 million raised as of the series E round last year plus the $200 million in structured equity announced today.
Founded in 2014, the company has created a massive "healthcare map," an artificial intelligence platform that compiles de-identified healthcare data from hundreds of sources and more than 330 million individual patients. It combines a repository of health data representing a massive trove of anonymized patients with the analytics software necessary to dig through that database.
Komodo uses these data to create software for companies like drugmakers and insurers. The company's platform offers real-time views into patient healthcare journeys so payers and life sciences companies can identify care disparities and conduct interventions.
https://www.fiercehealthcare.com/health-tech/komodo-health-banks-200m-equity-infusion-fuel-growth-it-restructures-cuts-headcount-9?mc_cid=5f21007524&mc_eid=5ffd7706aaAzalea Health Receives $45M Syndicated Debt Facility
Azalea Health, an Atlanta, GA-based provider of electronic health records and revenue cycle management solutions for community-based healthcare providers, received $45M in a Syndicated Debt facility.
The financing was provided by CIBC Innovation Banking.
The company intends to use the funds to continue to grow its business reach.
Led by CEO Baha Zeidan, Azalea Health provides a cloud-based SaaS solution that offers electronic health records integrated with telehealth functionality, revenue cycle management, and mobile health applications for rural, community and urban practices and hospitals.
The company serves a variety of ambulatory, inpatient, and specialty care settings, with a focus on helping underserved healthcare providers in the U.S.
Azalea Health Receives $45M Syndicated Debt Facility
Azalea Health, an Atlanta, GA-based provider of electronic health records and revenue cycle management solutions for community-based healthcare providers, received $45M in a Syndicated Debt facility
KeyCare Closes $27M Series A Funding
KeyCare, a Chicago, IL-based provider of a virtual-first care platform built with Epic, raised $27M in Series A funding.
Ziegler, and and two additional health systems joined 8VC, LRVHealth, Bold Capital, and Spectrum Health Ventures.
The company intends to use the funds to improve patient access, expand provider capacity, and streamline care delivery across the country.
Led by CEO Lyle Berkowitz, KeyCare is an Epic-based virtual care platform designed to help health systems improve access and quality by expanding their virtual care options for patients. The company offers health systems the ability to augment their care teams, optimize capacity, and widen their digital front doors by partnering with a nationwide network of virtual care groups working on KeyCare’s Epic-based platform. Patients can schedule appointments with these Virtualist healthcare providers via their health system’s MyChart portal or call center. Virtualists then complete the telehealth visit on the platform and their data can be shared with members of the patient’s regular care team.
KeyCare Closes $27M Series A Funding
KeyCare, a Chicago, IL-based provider of a virtual-first care platform built with Epic, raised $27M in Series A funding
RxAnte Receives $25M Growth Financing
RxAnte, a Washington, D.C-based pharmacy care management business company, received $25M in Growth financing.
Trinity Capital Inc. (NASDAQ: TRIN, TRINL), provided the facility. $15M was drawn under the facility, and RxAnte has the option to draw an additional $10M, subject to the conditions under the agreement.
The company intends to use the funds to expand its business reach, continuing its work with health plans to bring down the $528 billion annual cost of under-use, over-use, and misuse of prescription drugs.
Led by CEO Josh Benner, RxAnte is a provider of predictive analytics and targeted clinical programs that improve medication prescribing and adherence. A key component of its offering is its Mosaic Pharmacy Service, which provides value-based, in-home pharmacy services to medically complex and vulnerable seniors. Mosaic directly improves prescribing, adherence, and drug therapy outcomes for patients under our care with the objective of improving quality and lowering total cost of care.
RxAnte Receives $25M Growth Financing
RxAnte, a Washington, D.C-based pharmacy care management business company, received $25M in Growth financing
Nectar Raises Over $16.5M in Series A Funding
Nectar, a New York-based provider of an allergy care platform, raised $16.5m in Series A funding.
The round, which brought total equity raised to over $24m, was led by Harmony Partners, with participation from Juxtapose and Obvious Ventures.
The company intends to use the funds to invest in three key areas in 2023, scaling its virtual care platform nationwide, launching its first physical location to comprehensively treat allergies, and initiating clinical studies.
Led by CEO Kenneth Chahine, Nectar is building a vertically-integrated platform for allergies, including a hybrid virtual and physical clinic model, compounding pharmacy, lab testing facility, and an allergist physician network to align incentives and deliver customer experiences. The company offers custom-formulated drops for under the tongue, delivered right to patients’ homes. The dosage and formulation of the treatment come from patent-pending protocols that help a patient’s body tolerate their allergen triggers over time through a process called Sublingual Allergen Immunotherapy, training their immune system not to trigger an allergic reaction.
Nectar Raises Over $24M in Series A Funding
Nectar, a New York-based provider of an allergy care platform, raised $16.5m in Series A funding
Seeing double, digital therapeutic maker BehaVR absorbs OxfordVR alongside $13M VC round
With the goal of building a unified virtual reality platform to aid in treatments for mental and behavioral health, BehaVR and OxfordVR have joined forces—with a transatlantic transaction that’s raised an additional $13 million to boot.
The new digital therapeutic company will operate under the Tennessee-based BehaVR brand and will be led by BehaVR’s founder and CEO Aaron Gani. At the same time, the acquisition will be complemented by $13 million from a series B funding round.
That financing was led by Optum Ventures and Oxford Science Enterprises with additional backing from Confluent Health, Accenture Ventures, Chrysalis Ventures and Thornton Capital.
The company aims to help address anxiety, stress, pain and addiction through VR headsets in settings ranging from the clinic, group therapy sessions and the home, amid a shortage of trained providers.
Going forward, the new BehaVR plans to provide a range of VR-based digital therapeutics that allow for personalized experiences and care plans with connections to clinician oversight.
Wisdo Health Raises Additional $5M in Series A; Closes Round at $11M
Wisdo Health, a New York-based provider of a peer support platform focused on ending social isolation, raised additional $5M in Series A funding.
The round was led by Marius Nacht, Alive Israel Healthtech Fund and Bridge Builders Collaborative with participation from Anne Wojcicki, and Avram Miller. This additional funding closes the $11M A round. Michel Habib, Co-founder and Managing General Partner of Alive VC, will be joining the Wisdo Board.
The company intends to use the funds to accelerate growth and expand operations.
Led by Boaz Gaon, CEO and Founder, Wisdo Health is an evidence-based peer support and benefits navigation platform designed to address the consequences of loneliness, social isolation, and lack of engagement on health outcomes and costs. The company uses a data-driven model to map users’ life challenges, goals, and obstacles to health, then proactively connects them with helpful peers, group coaching to build social skills, and referrals to clinical and SDOH solutions offered to users through their employer, state, or health plan.
Wisdo Health Raises Additional $5M in Series A; Closes Round at $11M
Wisdo Health, a New York-based provider of a peer support platform focused on ending social isolation, raised additional $5M in Series A funding
Carallel raises $8.2M to expand caregiver support services
Carallel, which offers digital health and support tools for family caregivers, scooped up $8.2 million in Series A funding.
The round was led by FCA Venture Partners, with participation from investors including 450 Ventures, Create Health Ventures, Gratitude Railroad, Loud Capital and Wanxiang Healthcare Investments.
Carallel provides support for people caring for aging family members or loved ones with medical conditions. Its offerings include a team of advocates who can be contacted by phone, email or chat to listen to concerns and help figure out care plans.
The startup also provides a digital health platform called MyCareDesk, where users can research and find services like in-home care and financial planning or keep notes. It offers tools through health plans, providers and employers.
Carallel said it currently works with more than 400,000 Medicare Advantage and commercially insured members and caregivers nationally. It plans to use the capital from the Series A funding to partner with more Medicare Advantage and commercial insurers, develop digital tools, and expand peer-to-peer support and targeted care interventions.
Carallel raises $8.2M to expand caregiver support services | MobiHealthNews
The startup offers access to advocates who can help family caregivers make plans or solve problems as well as a digital health platform.
Porter Raises $5.4M in Seed Funding
Porter, a Miami, FL-based provider of a healthcare IT and services platform, raised $5.4M in Seed funding.
The round was led by Grit Capital Partners, Old Line Capital, and JLC Family Office.
The company intends to use the funds to strengthen its position as a technology and clinical services platform for care coordination and quality optimization, benefitting patients and payors alike.
Led by John Criswell, Founder & CEO, Porter is a healthcare IT and services platform connecting members with personalized services, products, and care coordination. Porter connects members with the personalized services, products, and information they need —navigable content, a curated marketplace, coverage information, and a supportive online health community. Driven by AI analytics, Porter’s virtual Care Guide Team helps the member navigate the healthcare delivery system and secures the right support for each member’s unique needs for care at home.
Porter Raises $5.4M in Seed Funding
Porter, a Miami, FL-based provider of a healthcare IT and services platform, raised $5.4M in Seed funding
Monarch Medical Technologies Receives $5M Investment from Semler Scientific
Monarch Medical Technologies, a Charlotte, NC-based digital health company, received a $5M in investment from Semler Scientific (Nasdaq: SMLR).
Semler Scientific, which provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, made the investment through the purchase of a senior secured convertible promissory note. Repayment of the note is secured by a first priority interest in all of Monarch’s assets. The investment in Monarch complements Semler Scientific’s offering of Insulin Insights™, a glycemic management software application that healthcare providers can use to optimize outpatient insulin dosing for persons with diabetes.
The company intends to use the funds to accelerate growth, expand operations and its business reach.
Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Its FDA-cleared EndoTool Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with a software application that integrates with all major EMR systems.
Monarch Medical Technologies Receives $5M Investment from Semler Scientific
Monarch Medical Technologies, a Charlotte, NC-based digital health company, received a $5M in investment from Semler Scientific (Nasdaq: SMLR)
Override Raises $3.5M in Seed Funding
Override, a Philadelphia, PA-based new multi-specialty, virtual chronic pain solution, raised $3.5m in seed funding.
The round was led by 7wireVentures and Martin Ventures, with participation from SignalFire and Confluent Health.
Founded by former US Secretary of Veterans Affairs, David Shulkin MD, and his daughter, Jennie Shulkin JD, Override uses the latest in pain neuroscience research to help patients make functional, behavioral, and movement-related changes needed to calm the nervous system and rewire pain neural pathways. Its non-opioid, virtual, one-stop-shop matches patients with a team of chronic pain specialists in pain medicine, physical therapy, and behavioral health. These specialists treat patients individually and work together as a team.
Override Raises $3.5M in Seed Funding
Override, a Philadelphia, PA-based new multi-specialty, virtual chronic pain solution, raised $3.5m in seed funding
Crescendo Health’s Funding Signals Growing Momentum For The Role Platforms Can Play In Clinical Trials Innovation
Crescendo Health, a public benefit corporation, formally announced its launch today with $3.4 million in seed funding from Define Ventures and various other early-stage investors.
Crescendo Health is a digital health company that aims to transform the way life science and clinical research organizations use patient health data to support clinical trials and other forms of research. The company partners with clinical research sponsors to collect comprehensive data on study participants – i.e. patients – from all kinds of places that are normally hard to access, including their payers, providers, EHRs and even other clinical trials.
Once Crescendo Health’s team gets informed consent from patients, it has the mandate to gather and synthesize previously hard-to-reach troves of data like pharma records, labs, or health insurance claims. Then Crescendo Health can package it up for research sponsors in whatever format fits their specific studies. The model is meant for an assortment of use cases within clinical research, such as health economics and outcomes research, post-marketing observational studies or safety registries, and longer-term follow-up or observational extension studies.
Crescendo Health’s Funding Signals Growing Momentum For The Role Platforms Can Play In Clinical Trials Innovation
Increasing access to clinical trials - for both patients as well as research sites - is critical as issues like clinical trial diversity, health equity and acceptance of RWD become more highly visible and important. Crescendo Health aims to do that by providing technology to patients.
St. Pete women's mental health company LunaJoy closes big seed round
LunaJoy, a St. Petersburg-based mental telehealth startup focused on girls' and women's needs during puberty, pregnancy, menopause and everything in between — closed its seed round at the end of 2022 with $2.4 million, Laddha and Rathi told Axios.
LunaJoy connects patients with medical staff who can assess their needs virtually and provide a path for care — from holistic therapy to psychiatry and mental health coaching. All appointments are conducted through a voice or video call on their website.
The company has grown rapidly since it launched in 2021, raising $1.9 million less than a month after Laddha and Rathi joined the Y Combinator tech accelerator program that year.
The site has insurance contracts with Cigna, Aetna, Humana and Magellan and is licensed in 17 states.
Only about half of women with depression receive treatment, according to the CDC, with the most common barriers to treatment being cost and stigma.
LunaJoy estimates its care services cost half of a typical mental health visit.
